Western Pennsylvania's trusted news source
New York attorney general tells hospitals to continue transgender care after Trump’s executive order | TribLIVE.com
Health

New York attorney general tells hospitals to continue transgender care after Trump’s executive order

Associated Press
8178037_web1_8178037-69358e62c24f48708d88c3e2cce4fc60
AP
New York Attorney General Letitia James speaks June 11, 2019, during a news conference, in New York.
8178037_web1_8178037-989e2b1420b6482faf44d47abfb18394
AP
Participants march June 4, 2023, during the 31st annual Queens Pride Parade and Multicultural Festival in New York.

NEW YORK — New York Attorney General Letitia James on Monday told hospitals that they would be violating state law if they stop offering gender-affirming care for people under age 19 in response to an executive order from President Donald Trump aimed at curtailing federal funding for such treatments.

In a letter, James told health care facilities that refusing to provide the treatments would violate New York’s anti-discrimination laws.

“Regardless of the availability of federal funding, we write to further remind you of your obligations to comply with New York State laws,” her letter reads.

Trump last week signed an executive order that directed agencies to take steps to make sure that hospitals receiving federal research and education grants “end the chemical and surgical mutilation of children.” The language in the order — using words such as “maiming,” “sterilizing” and “mutilation” — contradicts what is typical for gender-affirming care in the United States.

James’ message came as some hospitals in Colorado, Virginia and Washington, D.C., said they were pausing gender-affirming treatments for young people while administrators evaluate the order.

Emails seeking comment were sent to the Greater New York Hospital Association and the Healthcare Association of New York State.

Gender-affirming medical care for transgender youth is not common but such treatments have been the subject of fierce political debate. Fewer than 1 in 1,000 adolescents in the U.S. with commercial insurance received puberty blockers or hormones during a recent five-year period, according to a new study.

Remove the ads from your TribLIVE reading experience but still support the journalists who create the content with TribLIVE Ad-Free.

Get Ad-Free >

Categories: Health | News | U.S./World
Content you may have missed